Biosimilar strategic implementation at a large health system

Kar, Indrani; J. Kronz, Margaret; Kolychev, Evelina; Silverman, Paula; Mendiratta, Prateek; Tomlinson, Benjamin; Prunty, Jeremy; Copley, Melissa; Patel, Seema; Caudill, Sara; A. Farah, Lisa; Wesolowski, Bryan; Crissinger, Tyler; Kendig, Colin; Szymczak, Eric; Duraj, Lindsey; A. Dumot, John; Acheson, Emily; Lyamkin, Svetlana; King, Michelle; Mocilnikar, Allyson; Cunningham, Kevin; Paulic, Nikola; Botzki, Uwe; M. Lerman, Rachael; Strosaker, Robyn; Osborne, Shawn; Glotzbecker, Brett

doi:10.1093/ajhp/zxab410

Public

Biosimilar strategic implementation at a large health system

Published in American Journal of Health-System Pharmacy • Nov 1, 2021

Authors:

Indrani Kar

Margaret J. Kronz

Evelina Kolychev

Abstract

PURPOSE: This article highlights one health system's response to the market influx of biosimilars with the establishment of a process for formulary review and selection of preferred agents and support for therapeutic interchanges. SUMMARY: Through assessment of available literature, insurance payor ...

Subject

Biosimilar

Formulary

Product (mathematics)

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!